🟢 Marker Therapeutics is trading 6.78% up today as biotech and broader markets rise

Marker Therapeutics is trading at $1.05, up 6.78%, with the move most consistent with broad-market and biotech-sector strength.

• The supplied sector context reports XBI up 2.13%, while major U.S. indexes are also sharply higher.
• No November 4 company-specific announcement appears in the press-release listing. The latest listed announcement is the October 19 FDA grant, which is not a confirmed catalyst for this move.
• No live volume information was provided.